|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to health benefit plan coverage for certain obesity |
|
medications. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Chapter 1369, Insurance Code, is amended by |
|
adding Subchapter R to read as follows: |
|
SUBCHAPTER R. COVERAGE FOR CERTAIN OBESITY MEDICATIONS |
|
Sec. 1369.781. APPLICABILITY OF SUBCHAPTER. (a) This |
|
subchapter applies only to a health benefit plan that provides |
|
benefits for medical or surgical expenses incurred as a result of a |
|
health condition, accident, or sickness, including an individual, |
|
group, blanket, or franchise insurance policy or insurance |
|
agreement, a group hospital service contract, or an individual or |
|
group evidence of coverage or similar coverage document that is |
|
issued by: |
|
(1) an insurance company; |
|
(2) a group hospital service corporation operating |
|
under Chapter 842; |
|
(3) a health maintenance organization operating under |
|
Chapter 843; |
|
(4) an approved nonprofit health corporation that |
|
holds a certificate of authority under Chapter 844; |
|
(5) a multiple employer welfare arrangement that holds |
|
a certificate of authority under Chapter 846; |
|
(6) a stipulated premium company operating under |
|
Chapter 884; |
|
(7) a fraternal benefit society operating under |
|
Chapter 885; |
|
(8) a Lloyd's plan operating under Chapter 941; or |
|
(9) an exchange operating under Chapter 942. |
|
(b) Notwithstanding any other law, this subchapter applies |
|
to: |
|
(1) a basic coverage plan under Chapter 1551; |
|
(2) a basic plan under Chapter 1575; |
|
(3) a primary care coverage plan under Chapter 1579; |
|
and |
|
(4) the state Medicaid program, including the Medicaid |
|
managed care program operated under Chapter 540, Government Code. |
|
Sec. 1369.782. COVERAGE REQUIRED FOR CERTAIN OBESITY |
|
MEDICATIONS. A health benefit plan that provides prescription drug |
|
benefits must provide coverage for a prescription drug that is a |
|
glucagon-like peptide-1 receptor agonist to treat obesity. |
|
SECTION 2. If before implementing any provision of this Act |
|
a state agency determines that a waiver or authorization from a |
|
federal agency is necessary for implementation of that provision, |
|
the agency affected by the provision shall request the waiver or |
|
authorization and may delay implementing that provision until the |
|
waiver or authorization is granted. |
|
SECTION 3. Subchapter R, Chapter 1369, Insurance Code, as |
|
added by this Act, applies only to a health benefit plan delivered, |
|
issued for delivery, or renewed on or after January 1, 2026. |
|
SECTION 4. This Act takes effect September 1, 2025. |